Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology
Biotechnology · weight
2.43%
Industry change · 12M
-0.06 pp
Biotechnology · contribution
-0.055 pp
Company participation
100%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Oct 2020 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
AbbVie →
ABBV
United States$150.2bn0.711%+0.710 pp+0.098 pp+12.9%Yes
Biogen →
BIIB
United States$38.8bn0.184%+0.183 pp-0.097 pp-15.6%Yes
Regeneron Pharmaceuticals →
REGN
United States$51.1bn0.242%+0.242 pp+0.092 pp+77.5%Yes
Gilead Sciences →
GILD
United States$72.9bn0.345%+0.345 pp-0.075 pp-5.2%Yes
Amgen →
AMGN
United States$126.3bn0.598%+0.597 pp-0.062 pp+4.5%Yes
Vertex Pharmaceuticals →
VRTX
United States$54.2bn0.257%+0.256 pp-0.005 pp+6.6%Yes
Incyte →
INCY
United States$18.9bn0.090%+0.090 pp-0.005 pp+3.2%Yes

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.